BTIG analyst Ryan Zimmerman reiterated a Neutral rating on Orthofix International (NASDAQ: OFIX).The analyst comments "We maintain our Neutral following ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments

Form 10-K Orthofix Medical Inc. For: Dec 31February 25, 2025 7:09 AM Orthofix International (OFIX) Misses Q4 EPS by 61c ; Offers GuidanceFebruary 25, 2025 7:05 AM Form 8-K Orthofix Medical Inc. For: Feb 25February 25, 2025 7:04 AM Orthofix Reports Fourth Quarter and Full-Year 2024 Results and Provides 2025 Financial GuidanceFebruary 25, 2025 7:00 AM